Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ingenol Mebutate vs Imiquimod in Actinic Keratosis
NCT01926496Phase 4Completed
- Sponsor
- LEO Pharma
- Start
- Sep 2013
- Primary completion
- Jul 2019
- Modality
- Peptides, Small Molecules
- Countries
- 3
01
Overview
A Phase 4 trial of ingenol mebutate in actinic keratosis (AK), sponsored by LEO Pharma. Started Sep 2013; status: completed.
02
Drugs
ingenol mebutate
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT01926496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01926496.